New Market Report Now Available: EpiCast Report: Hemophilia - Epidemiology Forecast to 2022
Hemophilia is an X-linked hereditary bleeding disorder characterized by impaired blood coagulation as a result of deficiencies in the production or function of coagulation factor VIII (hemophilia A) or factor IX (hemophilia B). Because of the deficiency of coagulation factor, hemophilia patients have a tendency for bleeding in joints, muscles, soft tissues and within mucous membranes, which can be spontaneous or could be due to internal or external trauma, depending on the severity of the disease. The clinical presentation of...
View full press release